1. Adlercreutz H, Mazur W (1997) Phyto-oestrogens and western diseases. Ann Med 29: 95
2. Ascoli M, Fanelli F, Segaloff DL (2002) The lutropin/choriogonadotropin receptor, a 2002 perspective. Endocr Rev 23: 141
3. Barbieri RL, Osathanondh R, Ryan KJ (1981) Danazol inhibition of steroido-genesis in the human corpus luteum. Obstet Gynecol 57: 722
4. Barbieri RL, Speroff L, Walker AM, McPherson K (1999) Therapeutic controversy: the safety of third-generation oral contraceptives. J Clin Endocrinol Metab 84: 1822
5. Barrett-Connor E, Grady D, Sashegyi A et al. (2002) Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 287: 847–857